Litcius/Paper detail

Mitochondrial dysfunction and pancreatic islet β‑cell failure (Review)

Wenxin Sha, Fei Hu, Shizhong Bu

2020Experimental and Therapeutic Medicine48 citationsDOIOpen Access PDF

Abstract

Pancreatic &beta;‑cells are the only source of insulin in humans. Mitochondria uses pyruvate to produce ATP as an intermediate link between glucose intake and insulin secretion in &beta;‑cells, in a process known as glucose‑stimulated insulin secretion&nbsp;(GSIS). Previous studies have demonstrated that GSIS is negatively regulated by various factors in the mitochondria, including tRNA<sup>Leu</sup> mutations, high p58 expression, reduced nicotinamide nucleotide transhydrogenase activity, abnormal levels of uncoupling proteins and reduced expression levels of transcription factors&nbsp;A, B1 and B2. Additionally, oxidative stress damages mitochondria and impairs antioxidant defense mechanisms, leading to the increased production of reactive oxygen species, which induces &beta;‑cell dysfunction. Inflammation in islets can also damage &beta;‑cell physiology. Inflammatory cytokines trigger the release of cytochrome&nbsp;c from the mitochondria via the NF‑&kappa;B pathway. The present review examined the potential factors underlying mitochondrial dysfunction and their association with islet &beta;‑cell failure, which may offer novel insights regarding future strategies for the preservation of mitochondrial function and enhancement of antioxidant activity for individuals with diabetes mellitus.

Topics & Concepts

Beta cellMolecular medicineCell cycleOncogeneIsletMitochondrionCellInternal medicineBiologyEndocrinologyCancer researchMedicineDiabetes mellitusCell biologyCancerGeneticsPancreatic function and diabetesAdipose Tissue and MetabolismDiet, Metabolism, and Disease